Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. J Infect Dis. 2009 Jul 15; 200(2):202-5.